Xenon Pharmaceuticals
XENE
XENE
58 hedge funds and large institutions have $110M invested in Xenon Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 23 increasing their positions, 6 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
53% less capital invested
Capital invested by funds: $234M → $110M (-$124M)
Holders
58
Holding in Top 10
2
Calls
$6K
Puts
–
Top Buyers
| 1 | +$3.93M | |
| 2 | +$2.26M | |
| 3 | +$2.05M | |
| 4 |
BlackRock
New York
|
+$1.79M |
| 5 |
JPMorgan Chase & Co
New York
|
+$1.14M |
Top Sellers
| 1 | -$11.8M | |
| 2 | -$7.01M | |
| 3 | -$5.09M | |
| 4 |
JG
Jefferies Group
New York
|
-$4.3M |
| 5 |
BC
Boxer Capital
San Diego,
California
|
-$3.96M |